Canada markets close in 1 hour 49 minutes

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
247.54+3.42 (+1.40%)
As of 02:10PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close244.12
Open242.75
Bid247.26 x 1100
Ask247.36 x 1200
Day's Range242.09 - 247.85
52 Week Range178.58 - 283.90
Volume1,448,785
Avg. Volume3,077,630
Market Cap236.795B
Beta (5Y Monthly)0.36
PE Ratio (TTM)37.79
EPS (TTM)6.55
Earnings DateFeb. 03, 2022
Forward Dividend & Yield3.92 (1.61%)
Ex-Dividend DateFeb. 14, 2022
1y Target EstN/A
  • Reuters

    Germany's Evotec partners with Lilly to research metabolic diseases

    German biotech company Evotec said on Tuesday that it had entered into a drug discovery collaboration in metabolic diseases with U.S. drugmaker Eli Lilly. The total potential value of the collaboration, which will run for three years, is up to $1 billion. As part of the collaboration, Evotec will explore potential drug candidates for the treatment of diabetes and chronic liver disease, the Hamburg-based company said.

  • Zacks

    AbbVie's (ABBV) Rinvoq Gets FDA Nod for Atopic Dermatitis

    FDA approves AbbVie's (ABBV) Rinvoq for the treatment of moderate to severe atopic dermatitis in adults and children aged 12 and above. This is the third indication for Rinvoq in the United States.

  • Zacks

    Glaxo (GSK), Vir Seek EUA for Intramuscular Sotrovimab in US

    Glaxo (GSK) and Vir are looking to get authorization for the intramuscular administration of their COVID-19 drug candidate, sotrovimab, which is currently authorized for intravenous administration.